Hemotherapy and Hemostasis Service

The Hemotherapy and Hemostasis Service is part of the Clinical Institute of Hematological and Oncological Diseases (ICMHO). It provides comprehensive care for patients with hemorrhagic and thrombotic diseases or congenital erythrocyte pathology. Its activity also includes antithrombotic treatments, obtaining hematopoietic progenitors for the ICMHO Bank or for advanced therapies and carrying out therapeutic apheresis.

It is structured in two sections:

• Hemotherapy Section. The Haemotherapy section performs plasma replacements, in which the patient's plasma is replaced, in the context of autoimmune diseases, microangiopathies, hypercholesterolemia, parasite infection or poisoning, and in the context of immunoadsorption procedures, such as in transplants with ABO incompatibility. This section also performs cytoapheresis, in the treatment of graft-versus-host disease, in which hematopoietic progenitors, platelets, or leukocytes are collected. This collection may also be for photoapheresis.
• Hemostasis section. This section provides care to patients with coagulation disorders in outpatient, inpatient and Day Hospital consultations, and includes the administration of blood products. It carries out the diagnosis, treatment, training and follow-up of patients with bleeding problems, including haemophilia, thrombotic disease or antithrombotic treatment. The Erythropathology Consultation carries out the diagnosis and treatment of rare erythrocyte diseases.